-
-
-
Airoha Technology Launches Latest Flagship Wireless AI Audio SoC AB1595
Customer\'s Product to Hit the Market in Q1 2025 Enhancing Consumer Headset Speech Quality to Professional Grade
-
-
-
-
Seizing trends, shouldering responsibilities, and pursuing the greater good
BEIJING,Dec. 30,2024-- A report from People\'s Daily:International scholars have described the current global issues as a "multipronged mixed crisis." The Ukraine crisis,the ongoing Israel-P
-
-
-
-
U.S.-based LifeWave Celebrates 20x Growth in 5 Years with New Kaohsiung Branch Opening
TAIPEI,Dec. 30,2024-- Post-pandemic,global economies have faced numerous challenges. Yet,one company has defied the odds,achieving an astonishing 20-fold global revenue growth in just five years—from
-
-
-
-
CapitaLand Investment advances Sustainability leadership in 2024 by progressing toward decarbonisation milestones and recognition in leading global indexes
13th consecutive year on the Dow Jones Sustainability World Index and 16th straight year on the Asia Pacific Index,following MSCI,FTSE4Good and GRESB accolades
-
-
-
-
EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
CHANGZHOU,China,Jan. 1,2025-- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"),a leading short-distance transportation solutions provider in China,today announced th
-
-
-
-
ATFX 2024 Recap: A Year of Expansion, Innovation, and Global Leadership
HONG KONG,Jan. 2,2025-- As 2024 concludes,ATFX has reinforced its position as a global leader in financial services,marking significant milestones across multiple areas. The company expanded its footp
-
-
-
-
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM Infections
SHANGHAI,Jan. 2,2025-- Shanghai MicuRx Pharmaceutical Co.,Ltd. ("MicuRx"，688373.SH) announced that MRX-5,its self-developed anti-infection drug,has been granted Orphan Drug Designation (ODD
-
-
-
-
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
WUHAN,China,Jan. 3,2025-- Hanx Biopharmaceuticals,CO. Ltd,an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases,today
-
-
-
-
HZICC: BRLC launches initiatives for a global journey from Hangzhou
HANGZHOU,China,Jan. 2,2025-- Hangzhou,long renowned as a historic and cultural hub,is increasingly making strides in global cultural communication and trade with the help of the UCLG ASPAC on the Belt
-
-
-
-
CES 2025 Preview: TESSAN to Showcase Charging Solutions for Enhanced Connectivity and Convenience
LAS VEGAS,Dec. 25,2024-- The leading charging solution providerTESSAN has announced its participation in CES 2025,where it will present its latest innovations designed to enhance connectivity and conv
TESSAN / 01-03
-
Hotel management
Newest
